HomeStockWeather reportNetworkAwardees
Back to network

Partha Ray, PhD

University of California, San Diego

Co Investigator: Strategic Resource Development lead

AptamerMolecular DiagnosticsNucleic Acid TherapeuticsProtein Biochemistry
LinkedInWebsite

Related publications

In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein.

Bruna Andersen Pereira de Jesus, Anderson Albino Gomes, Alex E Clark, Tayse Andrade Rodrigues, Melissa Ledgerwood-Lee, Westley Van Zant, Howard Brickner, Meiqiao Wang, David L Blum, Maria B Cassera, Aaron F Carlin, Eliah S Aronoff-Spencer, Gustavo Felippe da Silva, Maria de Lourdes Borba Magalhães, Partha Ray
December 18, 2022

The recent development and mass administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines allowed for disease control, reducing hospitalizations and mortality. Most of these vaccines target the SARS-CoV-2…

Engineering Defensin α-helix to produce high-affinity SARS-CoV-2 Spike protein binding ligands.

Leonardo Antonio Fernandes, Anderson Albino Gomes, Maria de Lourdes Borba Magalhaes, Partha Ray, Gustavo Felippe da Silva
February 10, 2022

The binding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike protein to the Angiotensin-Converting Enzyme 2 (ACE2) receptor expressed on the host cells is a critical initial step for…

Tele-Neurorehabilitation During the COVID-19 Pandemic: Implications for Practice in Low- and Middle-Income Countries.

Abhishek Srivastava, Aishwarya Swaminathan, Manigandan Chockalingam, Murali K Srinivasan, Nirmal Surya, Partha Ray, Prasanna S Hegde, Preetie Shetty Akkunje, Sanjivani Kamble, Sonal Chitnis, Sureshkumar Kamalakannan, Suvarna Ganvir, Urvashi Shah
October 5, 2021

The importance of neurorehabilitation services for people with disabilities is getting well-recognized in low- and middle-income countries (LMICs) recently. However, accessibility to the same has remained the most significant challenge,…

Dataset on optimization and development of a point-of-care glucometer-based SARS-CoV-2 detection assay using aptamers.

Naveen K Singh, Partha Ray, Aaron F Carlin, Sydney C Morgan, Celestine Magallanes, Louise C Laurent, Eliah S Aronoff-Spencer, Drew A Hall
August 12, 2021

We present supplementary data for the published article, "Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer" [1]. The assay described is designed to be…

A systematic review and meta-analysis on correlation of weather with COVID-19.

Poulami Majumder, Partha Pratim Ray
May 24, 2021

This study presents a systematic review and meta-analysis over the findings of significance of correlations between weather parameters (temperature, humidity, rainfall, ultra violet radiation, wind speed) and COVID-19. The meta-analysis…

Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer.

Naveen K Singh, Partha Ray, Aaron F Carlin, Celestine Magallanes, Sydney C Morgan, Louise C Laurent, Eliah S Aronoff-Spencer, Drew A Hall
May 15, 2021

Significant barriers to the diagnosis of latent and acute SARS-CoV-2 infection continue to hamper population-based screening efforts required to contain the COVID-19 pandemic in the absence of widely available antiviral…

Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer

Naveen K Singh, Partha Ray, Aaron F Carlin, Celestine Magallanes, Sydney Morgan, Louise C Laurent, Eliah Aronoff-Spencer, Drew A. Hall
September 25, 2020

Significant barriers to the diagnosis of latent and acute SARS-CoV-2 infection continue to hamper population-based screening efforts required to contain the COVID-19 pandemic in the absence of effective antiviral therapeutics…

Anosmia, Ageusia and COVID-19.

Partha S Ray
January 1, 1970

COVID-19 is certainly the greatest global health problem now and for the foreseeable future. Clinicians and scientists from all over the world have been producing evidence to understand the epidemiology,…

Engineering defensin α-helix to produce high-affinity SARS-CoV-2 spike protein binding ligands.

Leonardo Antônio Fernandes, Anderson Albino Gomes, Beatriz Gomes Guimarães, Maria de Lourdes Borba Magalhães, Partha Ray, Gustavo Felippe da Silva
January 1, 1970

The binding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein to the angiotensin-converting enzyme 2 (ACE2) receptor expressed on the host cells is a critical initial step for…